Jazz Pharmaceuticals (JAZZ) PT Lowered to $214 at RBC Capital

March 2, 2022 6:37 AM EST Send to a Friend

RBC Capital analyst Daniel Busb ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Jazz Pharmaceuticals (JAZZ) PT Lowered to $214 at RBC Capital

Member Login

Free News Feed